Professional Documents
Culture Documents
Articulo Escojido
Articulo Escojido
1042/BJ20140153 237
WNK1 [with no lysine (K)] and WNK4 regulate blood pressure the Kelch domain β-propeller and the WNK4 degron motif.
by controlling the activity of ion co-transporters in the kidney. Importantly, many of the disease-causing mutations inhibit
Groundbreaking work has revealed that the ubiquitylation and binding by disrupting critical interface contacts. We also present
hence levels of WNK isoforms are controlled by a Cullin- the structure of the WNK4 degron motif in complex with KLHL2
RING E3 ubiquitin ligase complex (CRL3KLHL3 ) that utilizes
Abbreviations: BTB, Bric-a-brac, Tramtrack, and Broad complex; CRL3KLHL3 , Cullin3-RING ligase in complex with KLHL; CUL3, Cullin3; KEAP1, Kelch-
like enoyl-CoA hydratase-associated protein 1; KLHL, Kelch-like protein; NCC, Na + /Cl − ion co-transporter; NKCC2, Na + /K + /2Cl − co-transporter 2;
NRF2, nuclear factor-erythroid 2-related factor 2; OSR1, oxidative stress-responsive kinase 1; rTEV, recombinant tobacco etch virus; RT-PCR, reverse
transcription–PCR; SPAK, SPS1-related proline/alanine-rich kinase; TCEP, tris-(2-carboxyethyl)phosphine; TEV, tobacco etch virus; WNK, with no lysine
(K).
1
These authors contributed equally to this work.
2
Correspondence may be addressed to either of these authors (email alex.bullock@sgc.ox.ac.uk or t.kurz@dundee.ac.uk).
The structural co-ordinates reported for KLHL2 and KLHL3 will appear in the PDB under codes 4CHB and 4CH9 respectively.
c 2014 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which
permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
238 F.-R. Schumacher and others
importance that the interaction between the KLHL3 and acidic vector containing an N-terminal DAC tag [26] with a TEV
degron motif play in controlling the ubiquitylation and stability (tobacco etch virus) protease site downstream of the DAC
of WNK isoforms and therefore blood pressure. tag. DNA sequencing was performed by The Sequencing
CUL3 acts as a scaffolding protein that, through its N- Service, College of Life Sciences, University of Dundee, U.K.
terminus, binds to the BTB (Bric-a-brac, Tramtrack, and Broad (www.dnaseq.co.uk).
complex) domain in KLHL3 [16]. KLHL3 is the substrate- For structure determination, human KLHL2 (IMAGE clone
recognition subunit of the ubiquitin ligase complex, recruiting 4791972; residues 294–593) and human KLHL3 (NM_017415.2;
substrates for ubiquitylation via its associated Kelch domain residues 298–587) were cloned into the expression vector
[17–19]. The CUL3 C-terminus also interacts with the RING- pNIC28-Bsa4 (GenBank® accession number EF198106) by
finger protein RBX1 (ring-box 1), which binds to ubiquitin- ligation-independent cloning. This vector encodes for an N-
charged E2 enzymes and promotes transfer of ubiquitin terminal His6 tag and rTEV (recombinant TEV) cleavage site.
on to the bound substrate [20]. In addition to KLHL3,
CUL3 can form distinct E3 ligase complexes with other
General methods
BTB-domain-containing proteins [21,22]. There are close to
200 BTB domain proteins encoded in the human genome, Restriction enzyme digests, DNA ligations and other DNA
and although thus far only 11 BTB adaptor subunits have procedures, were performed using standard protocols. Site-
c 2014 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which
permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
Characterization of KLHL3–WNK kinase binding 239
wavelength of 538 nm, and measurements were corrected to the chain A (apo Kelch domain of KLHL2) as the search model.
fluorescent probe alone. Data analysis and graphing were then COOT [31] was used for manual model building and refinement,
performed in GraphPad Prism6; One Site Specific binding with whereas REFMAC [32] and PHENIX.REFINE [33] were used
Hill slope was assumed (model Y = Bmax ×X h /K d h + X h ) and the for automated refinement. TLS (Translation–Libration–Screw-
disassociation constant and associated S.E.M. was obtained. All rotation) parameters were included at later stages of refinement.
experimental bindings were repeated a minimum of two times Tools in COOT, PHENIX and MolProbity [34] were used to
and comparable results to those shown in the present study were validate the structures. Structure factors and co-ordinates have
obtained. been deposited in the PDB under 4CHB (KLHL2) and 4CH9
(KLHL3).
c 2014 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which
permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
240 F.-R. Schumacher and others
c 2014 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which
permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
Characterization of KLHL3–WNK kinase binding 241
the WNK1/4 degron motif bound to the Kelch domain of KLHL2 of an undesirable C-terminal carboxy group, or by changes
with similar affinity to KLHL3 (Figure 2C). In contrast, most of induced in the conformation of the peptide backbone.
the disease-causing mutations in KLHL3 are not conserved in the The overall β-propeller structure of the Kelch domain from
Kelch domain of KEAP1 (Figure 2B). the BTB-Kelch family has been well described [17,35–38]. Six
We determined the high-resolution crystal structures of the Kelch repeats, each composed of four antiparallel β-strands,
Kelch domains of human KLHL3 and KLHL2 in separate form the six blades of the barrel structure. The final strand at
complexes with the 11-residue WNK4 degron motif (Figure 2D). the C-terminus pairs with the N-terminal strand to complete
Two Kelch domains were found in the asymmetric unit of blade I (Figure 2D). In the present study, we show that KLHL3
each structure. The KLHL2 structure was solved at 1.6 Å and KLHL2 are structurally highly similar (Cα RMSD of
(1 Å = 0.1 nm) resolution in space group P43 21 2, whereas the 0.6 Å), and that both Kelch domains share a common mode
structure of KLHL3 was determined at 1.8 Å in space group of interaction with WNK4/1 peptide (Supplementary Figure
P21 21 21 . Data processing and refinement statistics for both S1A at http://www.biochemj.org/bj/460/bj4600237add.htm).
structures are presented in Table 2. Electron density for the WNK4 Comparison of these structures with the KLHL2 apo (unbound)
peptide was clearly visible in both structures after initial molecular structure determined previously (PDB code 2XN4), reveals
replacement and after refinement, the peptide was modelled into only minor conformational differences (Supplementary Figure
the binding site as shown in Figure 2(D) and Figure 3. For the S1B). This suggests that the KLHL3-binding site for WNK4 is
KLHL2 structure, residues 292–305 from the N-terminus and essentially rigid and conserved across both proteins.
residues 592–593 from the C-terminus were not clearly resolved
in the electron density and were excluded from the model, as was
the C-terminal residue of the WNK4 peptide (Gln567 ). Similarly,
residues 296–299 and 586–587 of KLHL3 could not be modelled Gordon’s syndrome mutations affect key residues in the
into the KLHL3–WNK4 complex, and WNK4 residues 566–567 KLHL3–WNK4 interface
and the side chains of Glu559 and Glu560 were also not defined Owing to the high level of similarity between the KLHL2–
(Figure 3A). The KLHL2 and KLHL3 structures were determined WNK4 and KLHL3–WNK4 structures, all remaining discussion
at pH 7.5 and pH 4.3 respectively, which probably contributes to focuses on the KLHL3 structure. The binding interface between
differences in the resolution of particular residues. For example, KLHL3 and WNK4 spans all six Kelch repeats and has a
protonation of WNK4 His566 may explain why this residue is not total buried surface area of 510 Å2 , with blades II, III and IV
clearly resolved in the crystal structure of the KLHL3 complex. participating in the greatest number of contacts (Figure 3B).
WNK4 Gln567 was disordered in both structures, consistent with Numerous contacts between KLHL3 and the WNK4 peptide can
a lack of stabilizing side-chain contacts, yet was critical for be observed, and together these interactions facilitate high-affinity
peptide binding (Figure 1D and Table 1). Although side-chain binding between these two proteins. A number of KLHL3 residues
substitutions were tolerated at this position (for example, Val547 in provide significant hydrophobic contact with WNK4; including
WNK3), truncations were likely disfavoured by the introduction Phe355 , Phe402 , Gly404 , Tyr449 , Gly451 and His498 (Figure 3C). Among
c 2014 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which
permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
242 F.-R. Schumacher and others
the KLHL3 residues, Arg360 contributes the greatest contact area identified with mutations in either of these residues and notably
and forms hydrogen bond interactions with WNK4 Glu557 , as mutation of Arg528 to a histidine residue is the most prevalent
well as with the main chain atoms of WNK4 Pro558 and Glu560 . KLHL3 mutation described thus far. A histidine side chain at this
KLHL3 Arg339 also forms a hydrogen bond with the main-chain position would potentially disrupt the local structure in KLHL3
carbonyl of WNK4 Glu559 . Other important polar interactions and would be too short to maintain a hydrogen-bond interaction
involve residues that are mutated in some instances of Gordon’s with WNK4. The WNK4 D564A mutation would similarly disrupt
syndrome (Figure 3D). For example, WNK4 Glu562 has the this interaction and indeed our independent binding experiments
greatest contact area of any interface residue and protrudes into using either KLHL3 R528H or WNK4 D564A (Figures 1B
the cleft between blades III and IV to hydrogen bond with and 1C) confirm the importance of this salt bridge for a high-
KLHL3 Ser432 (Figure 3D, right-hand panel). Mutations have affinity interaction. Finally, a buried water molecule is observed
been described at both sites in patients with Gordon’s syndrome to mediate hydrogen bonding between WNK4 Ala563 and the
(E562K and S432N respectively) [11,39] and would probably side chains of KLHL3 Ser432 and Ser433 (Figure 3D, right-hand
introduce steric clashes, as well the loss of hydrogen-bond panel). Gordon’s syndrome mutations at either position (S432N
formation. Perhaps the most notable interaction is the salt bridge or S433N) would disrupt this interaction network.
formed between KLHL3 Arg528 and WNK4 Asp564 (Figure 3D, Other Gordon’s syndrome mutations in KLHL3, including
middle panel). Patients with Gordon’s syndrome have been Q309R and N529K, are not involved in direct contact between the
c 2014 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which
permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
Characterization of KLHL3–WNK kinase binding 243
two proteins, but are situated within close proximity to the peptide- 19-residue peptide for KLHL3 N529K relative to wild-type
binding site (Figure 3D). These substitutions most likely disrupt KLHL3 (Figure 1B).
the interaction by unfavourably altering the shape and charge The remaining mutations identified in the Kelch domain of
of the binding pocket and by perturbing neighbouring residues KLHL3 (A340V, R384Q, L397P, S410L and A494T) lie in
in the binding interface. For example, the N529K mutation is sites disparate from the binding area. Arg384 and Ser410 form
predicted to perturb both the salt bridge between KLHL3 Arg528 an intramolecular hydrogen bond between blades II and III
and WNK4 Asp564 , and the van der Waals packing interactions that would be lost upon mutation, whereas A340V, L387P and
of KLHL3 Tyr577 . The importance of KLHL3 Asn529 for WNK4 A494T affect residues buried in the wild-type structure. All
binding is demonstrated by the decreased affinity of the WNK4 of these mutations are predicted to have a negative impact
c 2014 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which
permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
244 F.-R. Schumacher and others
Table 2 Crystallographic data collection and refinement statistics KLHL2 possess the conserved residues required to interact with
Relevant crystallographic statistics for the structures of KLHL2 and KLHL3 with WNK4 peptide the WNK degron motif [17].
(PDB codes 4CHB and 4CH9 respectively). Values in parentheses indicates data for the highest To promote efficient ubiquitylation of NRF2 by the KEAP1–
resolution shell. ASU, asymmetric unit. CUL3 ligase complex (CRL3KEAP1 ), both a high-affinity and
a low-affinity binding site must be engaged [41]. Given our
Parameter KLHL2–WNK4 peptide KLHL3–WNK4 peptide peptide-based approach, we did not investigate whether a second
low-affinity binding site is required for WNK ubiquitylation. It
Data collection would be interesting to investigate in future studies whether a
Space group P 43 2 1 2 P 21 21 21 second binding site does indeed exist in the WNK isoforms,
Cell constants
and furthermore, whether all Kelch substrates may have a
a , b , c (Å) 117.7, 117.7, 106.65 84.76, 45.33, 146.79
α, β, γ (◦ ) 90, 90, 90 90, 90, 90 high- and low-affinity degron site to fine tune substrate capture.
Resolution (Å) 39.52–1.52 (1.57–1.52) 73.40–1.84 (1.90–1.84) Alternatively, given that WNK isoforms are known to be able
Unique observations 114962 (11326) 49110 (4342) to form both hetero- and homo-dimers [42], these two high-
Completeness (%) 99.9 (39.52–1.56 Å) 98.0 (73.40–1.84 Å) affinity WNK degrons may be sufficient to engage separately
Redundancy 7.6 (7.0) 4.4 (3.0) the two Kelch domains within the KLHL3 dimer. In this model,
R merge 0.14 (1.1) 0.06 (0.25)
WNK dimerization may also influence WNK ubiquitylation
I /σ I 1.94 (at 1.52 Å) 3.58 (at 1.84 Å)
c 2014 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which
permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
Characterization of KLHL3–WNK kinase binding 245
KEAP1 Kelch domain, compared with blades II, III and IV for ACKNOWLEDGEMENTS
the KLHL2/3–WNK4 complex. Despite the apparent structural
We thank the staff at Diamond Light Source for their assistance with data collection
similarity of the Kelch domain backbones, the binding pockets experiments and Paul Davies and Jinwei Zhang for their advice on fluorescence polarization
bear no resemblance to one another in terms of both 3D shape and studies. We also acknowledge the excellent technical support of the MRC Protein
the position of contact residues across the pocket (Figures 4B Phosphorylation and Ubiquitylation Unit DNA Sequencing Service (co-ordinated by
and 4C). These differences help to explain the exquisite specificity Nicholas Helps), the cloning team (co-ordinated by Rachel Toth and Mark Peggie) and
of these adaptor proteins for their substrates, which is essential for the protein purification team (Mark Dorward, Daryn Mowbray, James Hastie and Axel
Knebel).
ensuring the specific regulation of ubiquitylation, and also clearly
have implications for the development of selective small-molecule
inhibitors of the KEAP1 Kelch domain [48].
Mutations in KEAP1 have also been identified in human FUNDING
disease, most notably cancers of the lung, breast and gall This work was supported by the Medical Research Council, an ERC Starting Investigator
bladder [37,49,50]. Parallel to Gordon’s syndrome mutations in Grant (to T.K.), as well as the pharmaceutical companies supporting the Division of
KLHL3, several of the reported KEAP1 mutations directly perturb Signal Transduction Therapy Unit (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline,
the interface with NRF2, whereas others are likely to disrupt the Merck, Janssen Pharmaceutica and Pfizer). The SGC (Structural Genomics Consortium)
is a registered charity (number 1097737) that receives funding from AbbVie, Boehringer
structural integrity of the Kelch domain fold. Of these, many
Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health
are found at the recurring double glycine motif on the second Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis
β-strand of Kelch repeats I, II, III and IV. The double glycine Research Foundation, the Ontario Ministry of Economic Development and Innovation,
motif is conserved in KLHL2 and KLHL3 (Figure 2B), but there Pfizer, Takeda and the Wellcome Trust [grant number 092809/Z/10/Z].
are currently no reported Gordon’s syndrome mutations at these
sites. Most described Gordon’s syndrome mutations in KLHL3 are
located either close to the peptide binding site or more randomly REFERENCES
throughout the structure with no recognizable pattern between the
Kelch repeats. It is clear that, despite the broad similarities in 1 Richardson, C., Rafiqi, F. H., Karlsson, H. K. R., Moleleki, N., Vandewalle, A., Campbell,
D. G., Morrice, N. A. and Alessi, D. R. (2008) Activation of the thiazide-sensitive
the structural fold of KEAP1 and KLHL2/KLHL3, there are
Na + -Cl − cotransporter by the WNK-regulated kinases SPAK and OSR1. J. Cell Sci.
crucial differences in the way these proteins interact with their
121, 675–684 CrossRef PubMed
substrates. 2 Arroyo, J. P. and Gamba, G. (2012) Advances in WNK signaling of salt and potassium
The findings described in the present paper provide important metabolism: clinical implications. Am. J. Nephrol. 35, 379–386 CrossRef PubMed
new insights into the regulation of WNK kinases by CRL3KLHL3 3 Gagnon, K. B. and Delpire, E. (2012) Molecular physiology of SPAK and OSR1: two
and, moreover, shed light on the very diverse mode of interactions Ste20-related protein kinases regulating ion transport. Physiol. Rev. 92,
between substrates and their E3 ligases. In the future, it will 1577–1617 CrossRef PubMed
be important to determine the contribution of KLHL2 to blood 4 Wu, G. and Peng, J.-B. (2013) Disease-causing mutations in KLHL3 impair its effect on
pressure regulation, to understand if all WNK isoforms are indeed WNK4 degradation. FEBS Lett. 587, 1717–1722 CrossRef PubMed
substrates of CRL3KLHL3 and to elucidate if and how WNK 5 Kahle, K. T., Ring, A. M. and Lifton, R. P. (2008) Molecular physiology of the WNK
degradation is regulated by external signals. kinases. Annu. Rev. Physiol. 70, 329–355 CrossRef PubMed
6 Ohta, A., Schumacher, F.-R., Mehellou, Y., Johnson, C., Knebel, A., Macartney, T. J.,
Wood, N. T., Alessi, D. R. and Kurz, T. (2013) The CUL3-KLHL3 E3 ligase complex
mutated in Gordon’s hypertension syndrome interacts with and ubiquitylates WNK
isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction. Biochem.
J. 451, 111–122 CrossRef PubMed
AUTHOR CONTRIBUTION 7 Wakabayashi, M., Mori, T., Isobe, K., Sohara, E., Susa, K., Araki, Y., Chiga, M., Kikuchi,
Frances-Rose Schumacher performed the fluorescent binding experiments and analysis. E., Nomura, N., Mori, Y. et al. (2013) Impaired KLHL3-mediated ubiquitination of WNK4
Fiona Sorrell crystallized the KLHL2–WNK and KLHL3–WNK degron complexes and causes human hypertension. Cell Rep. 3, 858–868 CrossRef PubMed
solved their structure. Fiona Sorrell, Frances-Rose Schumacher and Alex Bullock analysed 8 Mori, Y., Wakabayashi, M., Mori, T., Araki, Y., Sohara, E., Rai, T., Sasaki, S. and Uchida, S.
the structures. All authors were involved in planning the experiments, discussing data and (2013) Decrease of WNK4 ubiquitination by disease-causing mutations of KLHL3 through
writing the paper. different molecular mechanisms. Biochem. Biophys. Res. Comm. 439, 30–34 CrossRef
c 2014 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which
permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
246 F.-R. Schumacher and others
9 Shibata, S., Zhang, J., Puthumana, J., Stone, K. L. and Lifton, R. P. (2013) Kelch-like 3 31 Emsley, P., Lohkamp, B., Scott, W. G. and Cowtan, K. (2010) Features and development of
and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 CrossRef PubMed
WNK4. Proc. Natl. Acad. Sci. U.S.A. 110, 7838–7843 CrossRef PubMed 32 Murshudov, G. N., Vagin, A. A. and Dodson, E. J. (1997) Refinement of macromolecular
10 Wilson, F. H., Disse-Nicodème, S., Choate, K. A., Ishikawa, K., Nelson-Williams, C., structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53,
Desitter, I., Gunel, M., Milford, D. V., Lipkin, G. W., Achard, J. M. et al. (2001) Human 240–255 CrossRef PubMed
hypertension caused by mutations in WNK kinases. Science 293, 33 Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd,
1107–1112 CrossRef PubMed J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W. et al. (2010) PHENIX: a
11 Boyden, L. M., Choi, M., Choate, K. A., Nelson-Williams, C. J., Farhi, A., Toka, H. R., comprehensive Python-based system for macromolecular structure solution. Acta
Tikhonova, I. R., Bjornson, R., Mane, S. M., Colussi, G. et al. (2012) Mutations in Crystallogr. D Biol. Crystallogr. 66, 213–221 CrossRef PubMed
Kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 482, 34 Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J.,
98–102 CrossRef PubMed Murray, L. W., Richardson, J. S. and Richardson, D. C. (2010) MolProbity: all-atom
12 Gamba, G. (2005) Molecular physiology and pathophysiology of electroneutral structure validation for macromolecular crystallography. Acta Crystallogr. D Biol.
cation-chloride cotransporters. Physiol. Rev. 85, 423–493 CrossRef PubMed Crystallogr. 66, 12–21 CrossRef PubMed
13 de los Heros, P., Alessi, D. R., Gourlay, R., Campbell, D. G., Deak, M., Macartney, T. J., 35 Gray, C. H., McGarry, L. C., Spence, H. J., Riboldi-Tunnicliffe, A. and Ozanne, B. W.
Kahle, K. T. and Zhang, J. (2014) The WNK-regulated SPAK/OSR1 kinases directly (2009) Novel beta-propeller of the BTB-Kelch protein Krp1 provides a binding site for
phosphorylate and inhibit the K + -Cl − co-transporters. Biochem. J. 458, Lasp-1 that is necessary for pseudopodial extension. J. Biol. Chem. 284,
559–573 CrossRef PubMed 30498–30507 CrossRef PubMed
14 Arroyo, J. P., Kahle, K. T. and Gamba, G. (2013) The SLC12 family of electroneutral 36 Li, X., Zhang, D., Hannink, M. and Beamer, L. J. (2004) Crystal structure of the Kelch
c 2014 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which
permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
Biochem. J. (2014) 460, 237–246 (Printed in Great Britain) doi:10.1042/BJ20140153
(A) Superimposition of the crystal structures of KLHL2–WNK4 (blue with green peptide) and KLHL3–WNK4 (pink with yellow peptide) reveals the similarity between the two complexes. The key
contact residues are labelled (left panel). Multiple conformations are visible for Arg528 and Tyr577 in the KLHL2 structure. His566 and the side chains from Glu559 and Glu560 of WNK4 are traceable in
the KLHL2 structure, but are absent in the KLHL3 structure (right-hand panel). (B) Comparison of the apo (orange, PDB code 2XN4) and WNK4-bound structures of KLHL2 (blue) reveals the rigidity
of the Kelch β-propeller and peptide-binding site. Electron density for the bound peptide is shown on the right-hand panel.
1
These authors contributed equally to this work.
2
Correspondence may be addressed to either of these authors (email alex.bullock@sgc.ox.ac.uk or t.kurz@dundee.ac.uk).
The structural co-ordinates reported for KLHL2 and KLHL3 will appear in the PDB under codes 4CHB and 4CH9 respectively.
c 2014 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which
permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.